15012-36-9 Usage
Description
Methyl 2,3-dimethylbenzoate, also known as 2,3-dimethylbenzoic acid methyl ester, is an organic compound that serves as a valuable synthetic intermediate in the chemical industry. It is characterized by its aromatic structure, featuring a benzene ring with two methyl groups at the 2nd and 3rd positions and a methyl ester functional group. Methyl 2,3-dimethylbenzoateis known for its potential applications in various fields due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
Methyl 2,3-dimethylbenzoate is used as a synthetic intermediate for the production of 2,3-Dihydro-1H-isoindole-4-carboxylic Acid (D450070). Methyl 2,3-dimethylbenzoateis a crucial reagent in the synthesis of aminoalkylbenzoic acid derivatives, which have significant therapeutic applications in the treatment of various medical conditions.
Methyl 2,3-dimethylbenzoate is used as a precursor for the development of medications targeting faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, neuropathic pain, neuropathological disorders, and sleep disorders. Its role in the synthesis of these therapeutic agents highlights its importance in the pharmaceutical industry, contributing to the development of novel treatments for a wide range of health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 15012-36-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,0,1 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 15012-36:
(7*1)+(6*5)+(5*0)+(4*1)+(3*2)+(2*3)+(1*6)=59
59 % 10 = 9
So 15012-36-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O2/c1-7-5-4-6-9(8(7)2)10(11)12-3/h4-6H,1-3H3
15012-36-9Relevant articles and documents
COMPOUNDS
-
Page/Page column 46, (2018/12/03)
Provided are benzoxazolinone sulfonamide derivatives that inhibit Na v1.7 activity, pharmaceutical compositions containing them and their use in therapy for the treatment of diseases mediated by Na v1.7 activity.
Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity
Ruchelman, Alexander L.,Man, Hon-Wah,Zhang, Weihong,Chen, Roger,Capone, Lori,Kang, Jian,Parton, Anastasia,Corral, Laura,Schafer, Peter H.,Babusis, Darius,Moghaddam, Mehran F.,Tang, Yang,Shirley, Michael A.,Muller, George W.
, p. 360 - 365 (2013/02/23)
A series of analogs of the immunomodulary drugs lenalidomide (1) and pomalidomide (2), in which the amino group is replaced with various isosteres, was prepared and assayed for immunomodulatory activity and activity against cancer cell lines. The 4-methyl and 4-chloro analogs 4 and 15, respectively, displayed potent inhibition of tumor necrosis factor-α (TNF-α) in LPS-stimulated hPBMC, potent stimulation of IL-2 in a human T cell co-stimulation assay, and anti-proliferative activity against the Namalwa lymphoma cell line. Both of these analogs displayed oral bioavailability in rat.
ANTIVIRAL COMPOUNDS AND USE THEREOF
-
Page/Page column 31, (2009/12/02)
The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.